From: PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome
Univariate logistic regression | Multivariate logistic regression | ||||
---|---|---|---|---|---|
Variable | Odds ratio | 95% conf. interval | p | Odds ratio | 95% conf. interval |
Age | 1.09 | 1.02–1.17 | 0.007 | – | – |
Age_categorical (< 55 years or ≥ 55 years) | 5.71 | 1.07–30.39 | 0.041 | 5.65e+07 | n.a. |
Sex | 0.03 | 0.07–1.38 | 0.125 | 8.70e−09 | n.a. |
Side of primary tumor | 1.01 | 0.37–2.77 | 0.979 | – | – |
Histological subtype | 5.75 | 1.02–32.16 | 0.046 | 2.15 | 0.17–25.94 |
Vascular invasion | 4.10 | 0.77–21.76 | 0.097 | 31.71 | 0.68–1476.97 |
Status of margins | 1.77 | 0.38–8.26 | 0.466 | – | – |
T parameter | 3.00 | 0.67–13.40 | 0.150 | 0.19 | 0.01–6.75 |
N parameter | 0.18 | 0.02–1.61 | 0.128 | 0.16 | 0.01–2.32 |
PSMA positivity | 0.23 | 0.11–0.48 | 0.000 | 0.16 | 0.01–1.94 |
% PSMA expression | 1.02 | 1.00–1.05 | 0.042 | – | – |
PSMA 3-point score | 2.13 | 0.71–6.37 | 0.174 | – | – |
Cumulative PSMA score | 2.26 | 0.85–6.05 | 0.101 | – | – |